EUVIMEDEUVIMED entdecken
Crossref

Photoactivated chromophore for keratitis—Corneal cross‐linking in dogs and cats: A retrospective study in Italy

Manuela Crasta, Eva Gimenez iD, Pier Carlo Ostan, Kevin Arteaga iD

Veterinary Ophthalmology · 2025

DOI: 10.1111/vop.13284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2025. Verfasst von Manuela Crasta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Visionvet Anicura Eye Clinic, Bologna, Italy. Hauptthemen laut MEDLINE: Dog Diseases, Cat Diseases, Keratitis, Cross-Linking Reagents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the success and failure rate of photoactivated chromophore for keratitis—corneal cross‐linking (PACK‐CXL) therapy in a single population of dogs and cats. To identify the usefulness of the PACK‐CXL based on ulcer depth and establish a cutoff at which this procedure could be recommended. To analyze the influence of the different variables in corneal healing time and to report the presence of secondary endothelial damage and cataract formation. Materials and Methods Medical records of dogs and cats with presumptive infectious keratitis which underwent accelerated epithelium‐off PACK‐CXL between 2016 and 2023 were reviewed and analyzed.

Results

Records for 369 animals were included, and the overall success rate for healing was 97% (range 4–74 days and no rescue procedure). The second success (re‐epithelialization 66.5%. Animals who suffered from keratomalacia and hypopyon at presentation, or were treated with topical serum or gentamicin after PACK‐CXL showed an increase in epithelial healing time (EHT). Increasing age, brachycephalic conformation, keratomalacia alone, and deeper ulcers were identified as risk factors for the treatment outcome. Secondary endothelial injury or cataract formation was not noted in this study.

Conclusions

Accelerated PACK‐CXL is a non‐invasive, adjunctive treatment to medical therapy, which can be used in presumed infectious keratitis with a high probability of success. However, it is important to take in consideration the patient age, skull conformation, presence of keratomalacia, and the ulcer depth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesCat DiseasesKeratitisCross-Linking ReagentsPhotosensitizing AgentsRiboflavinAnimalsCatsDogsRetrospective StudiesItalyFemaleMaleCorneal UlcerTreatment OutcomeCorneal Cross-Linking

Stichwörter der Autor:innen

caninecorneal ulcerfelinephotoactivated chromophore for keratitis—corneal cross‐linking

Substanzen

Cross-Linking ReagentsPhotosensitizing AgentsRiboflavin

Autor:innen und Institutionen

  • Visionvet Anicura Eye Clinic, Bologna, Italy.

ORCID-Profile: Eva Gimenez, Kevin Arteaga

Zitieren

APA

Crasta, M., Gimenez, E., Ostan, P. C., & Arteaga, K. (2025). Photoactivated chromophore for keratitis—Corneal cross‐linking in dogs and cats: A retrospective study in Italy. Veterinary Ophthalmology. https://doi.org/10.1111/vop.13284

Vancouver

Crasta M, Gimenez E, Ostan PC, Arteaga K. Photoactivated chromophore for keratitis—Corneal cross‐linking in dogs and cats: A retrospective study in Italy. Veterinary Ophthalmology. 2025. doi:10.1111/vop.13284

BibTeX
@article{Crasta2025,
  author = {Crasta, Manuela and Gimenez, Eva and Ostan, Pier Carlo and Arteaga, Kevin},
  title = {Photoactivated chromophore for keratitis—Corneal cross‐linking in dogs and cats: A retrospective study in Italy},
  journal = {Veterinary Ophthalmology},
  year = {2025},
  doi = {10.1111/vop.13284}
}
Kostenlos starten →